SCHEMBL21717341

SCHEMBL21717341

Clc1cccc2cc3c(cc12)c1ccccc1n3-c1nc(-c2cccc3c2oc2ccccc23)nc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.40
CYP3A4 P08684 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
CYP2D6 P10635 4/20 0.40
CYP2C19 P33261 4/20 0.40
HSD17B10 Q99714 3/20 0.40
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
ABCB1 P08183 1/20 0.40
CLK4 Q9HAZ1 3/20 0.38
USP2 O75604 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
PIM1 P11309 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21213583 0.90 ALOX5 (0.37) CYP1A2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL21717342 0.90 ALOX5 (0.34) CYP1A2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL21716571 0.88 ALOX5 (0.33) CYP1A2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL21717261 0.85 ALOX5 (0.31) MAPTALOX5
SCHEMBL21716873 0.84 ALOX5 (0.30) MAPTALOX5
SCHEMBL21717374 0.84 MEN1 (0.43) CYP1A2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL21213758 0.80 ALOX5 (0.36) CYP1A2CYP2C19PIK3CDPIK3CBPRKDC
SCHEMBL21213102 0.80 PIK3CA (0.40) HSD17B10MAPTPIK3CDPIK3CBPRKDC
SCHEMBL21212866 0.79 CYP1A2 (0.35) CYP1A2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL21212993 0.79 ALOX5 (0.34) CYP1A2CYP3A4MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 CYP1A2 6/4885CYP3A4 10/4885MEN1 200/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 CYP1A2 6/4885CYP3A4 10/4885MEN1 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.